CPRX
Catalyst Pharmaceuticals Inc
NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY
$28.26
-4.01% today
Updated 2026-04-29
Market cap
$3.45B
P/E ratio
16.82
P/S ratio
5.86x
EPS (TTM)
$1.68
Dividend yield
—
52W range
$19 – $33
Volume
1.5M
Catalyst Pharmaceuticals Inc (CPRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $789450.00 | $20.62M | $16.68M | $12.03M | $7.97M | $5.83M | $6.25M | $16.79M | $25.37M | $43.91M | $60.10M | $41.71M | $85.39M | $60.45M | $112.38M | $192.35M | $237.79M | $375.63M | $470.11M | $851.41M |
| Cash & equivalents | $771127.00 | $20.43M | $15.94M | $11.77M | $7.78M | $5.48M | $6.03M | $1.41M | $2.22M | $9.10M | $28.24M | $13.89M | $57.50M | $16.56M | $89.51M | $130.24M | $171.44M | $298.39M | $137.64M | $517.55M |
| Current assets | $771567.00 | $20.59M | $16.53M | $11.92M | $7.89M | $5.78M | $6.23M | $16.73M | $25.32M | $43.83M | $59.90M | $41.45M | $85.19M | $55.19M | $111.36M | $159.24M | $210.11M | $320.81M | $219.33M | $623.61M |
| Total liabilities | $342988.00 | $772846.00 | $357165.00 | $1.47M | $348522.00 | $313709.00 | $2.49M | $2.17M | $3.98M | $8.67M | $4.63M | $2.40M | $4.42M | $9.67M | $24.75M | $22.76M | $30.96M | $75.21M | $82.23M | $123.78M |
| Current liabilities | $342988.00 | $772846.00 | $303285.00 | $1.43M | $294152.00 | $298961.00 | $833801.00 | $1.65M | $2.14M | $5.86M | $3.44M | $2.09M | $4.27M | $9.51M | $24.10M | $22.76M | $27.06M | $57.59M | $76.06M | $120.68M |
| Long-term debt | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Shareholder equity | $446462.00 | $19.85M | $16.32M | $10.56M | $7.62M | $5.52M | $3.76M | $14.62M | $21.39M | $35.24M | $55.48M | $39.31M | $80.96M | $50.78M | $87.63M | $169.60M | $206.83M | $300.42M | $387.88M | $727.63M |
| Retained earnings | $-3.03M | $-5.76M | $-9.90M | $-20.46M | $-27.71M | $-31.71M | $-38.10M | $-42.18M | $-54.33M | $-69.84M | $-90.08M | $-108.15M | $-126.56M | $-160.56M | $-128.69M | $-53.70M | $-26.31M | $49.86M | $121.27M | $285.16M |
| Accounts receivable | — | $85787.00 | $63709.00 | $12153.00 | — | $134025.00 | — | — | — | $3.50M | — | — | — | — | $10.54M | $5.99M | $6.72M | $10.79M | $53.51M | $65.49M |
| Inventory | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $56012.00 | $1.96M | $4.65M | $7.87M | $6.80M | $15.64M | $19.54M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |